Fabiana G. Radicati
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Associations of daily step counts with cognitive, clinical, and resting-state electroencephalographic measures in patients with cognitive decline due to Alzheimer's disease.
Journal: GeroScience
Published: April 14, 2026
Gender differences in non-motor symptoms in Parkinson's disease: a multicenter longitudinal study.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: February 11, 2026
Comparative effect of vortioxetine and sertraline on clinical and inflammatory profile in Parkinson's disease with comorbid depression.
Journal: Frontiers in neuroscience
Published: December 05, 2025
Effects of combined Mediterranean diet and physical activity intervention on the gut microbiome and disease progression in individuals with Parkinson's disease: study protocol for a multicenter, randomized controlled pilot study (PRIME study).
Journal: Frontiers in aging neuroscience
Published: November 10, 2025
Deep transcranial magnetic stimulation in progressive supranuclear palsy: a randomized double-blind, cross-over study.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: April 04, 2025
Dysphagia and oropharyngeal bradykinesia in Parkinson's disease.
Journal: Journal of neural transmission (Vienna, Austria : 1996)
Published: March 27, 2025
Gender Is the Main Predictor of Wearing-Off and Dyskinesia in Levodopa-Naïve Patients with Parkinson's Disease.
Journal: Movement disorders clinical practice
Published: February 18, 2025
Randomized Observer-Blind Study on the Effects of Neuromuscolar Taping in Parkinson's Disease Patients.
Journal: Movement disorders clinical practice
Published: January 09, 2025
Vortioxetine for the Treatment of Depression in Patients with Parkinson's Disease: A 16-week Pilot, Prospective, Open-label Safety Study.
Journal: Current neuropharmacology
Published: January 03, 2025
Vortioxetine for the Treatment of Depression in Patients with Parkinson's Disease: A 16-week Pilot, Prospective, Open-label Safety Study.
Journal: Current neuropharmacology
Published: January 03, 2025
Correction to: Gender differences in microRNA expression in levodopa‑naive PD patients.
Journal: Journal of neurology
Published: May 08, 2023
Gender differences in microRNA expression in levodopa-naive PD patients.
Journal: Journal of neurology
Published: February 21, 2023
Last Updated: 09/26/2026